The transfection technologies global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Transfection Technologies Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The transfection technologies market size has grown strongly in recent years. It will grow from $1.11 billion in 2023 to $1.21 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to the increasing prevalence of chronic diseases, expanded applications of transfection technologies, growing demand for cell & gene therapy, increasing R&D investments, and rising cancer incidences.
The transfection technologies market size is expected to see strong growth in the next few years. It will grow to $1.70 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to the rising rate of chronic and immunological diseases, the growing need for cell-based therapies, increasing demand for protein production, rising investments and funding in the development of drug delivery systems, and rising demand for monoclonal antibodies. Major trends in the forecast period include a rise in research and development in the field of cell-based therapies, adoption of the technologically advanced transfection method, increasing demand for advanced therapeutic delivery systems, increasing use of dual-reporter assays and co-transfection experiments, and increasing focus on personalized medicine.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Market Drivers –
The rise in gene therapy is expected to propel the growth of the transfection technologies market going forward. Gene therapy is a technique that aims to treat or prevent diseases by modifying genes, which includes inserting, repairing, or replacing faulty genes. Gene therapy’s rise is driven by progress in genetic research, enhanced delivery methods, and its ability to treat previously incurable genetic conditions. Transfection technologies are crucial for gene therapy, facilitating the precise, safe, and effective delivery of genetic material into cells. They support both temporary and permanent genome modifications, essential for treating genetic diseases and cancers. For instance, in July 2023, according to the report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, and Citeline, a US-based provider of drugs and devices, by the end of the first quarter (Q1) of 2023, there were 247 gene therapies in Phase II. This number increased by 5%, reaching 260 by the end of the second quarter (Q2). Therefore, the rise in gene therapy is driving the growth of the transfection technologies market.
Market Trends –
Major companies in the transfection technologies market are focused on developing advanced technology, such as mechanoporation transfection systems, to enable more complex and personalized applications in research and therapeutics. Mechanoporation transfection systems use mechanical forces to create temporary pores in cell membranes, allowing genetic material to enter cells. This method is efficient and minimally invasive, preserving better cell viability. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched CellPore, an innovative transfection system. This system includes a benchtop unit and the CellPore Transfection Kit 300, which comes with a specialized reagent kit and single-use delivery cartridges. Using controlled, rapid deformation in microfluidic channels, CellPore efficiently introduces small molecules, nucleic acids, proteins, and gene editing complexes into cells, ensuring minimal cell disruption and high viability. These features are critical for advancing research and the development of cutting-edge cell and gene therapies.
The transfection technologies market covered in this report is segmented –
1) By Product: Kits And Reagents, Equipment, Other Products
2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods
3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users
Get an inside scoop of the transfection technologies market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp
Regional Insights –
North America was the largest region in the transfection technologies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.
Table of Contents
1. Executive Summary
2. Transfection Technologies Market Report Structure
3. Transfection Technologies Market Trends And Strategies
4. Transfection Technologies Market – Macro Economic Scenario
5. Transfection Technologies Market Size And Growth
…..
27. Transfection Technologies Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
